Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5 results about "Nucleoside monophosphate" patented technology

Structural elements of three nucleotides—where one-, two- or three-phosphates are attached to the nucleoside (in yellow, blue, green) at center: 1st, the nucleotide termed as a nucleoside monophosphate is formed by adding a phosphate group (in red); 2nd, adding a second phosphate group forms a nucleoside diphosphate; 3rd, adding a third phosphate ...

Uracil-producing strain, construction method and application thereof

ActiveCN119432702BBacteriaMicroorganism based processesHeterologousCarbamoyl phosphate synthesis
This application relates to the field of metabolic engineering and genetic engineering technology for production, specifically providing a uracil-producing strain, its construction method, and its application. This strain is... E. coli Knockout of the uridine kinase gene in the W3110 genome udk Simultaneously integrates the T7 RNA polymerase gene; weakens the uridine kinase gene. pyrH Overexpression of carbamoyl phosphate synthase gene carAB ribose-phosphokinase gene prsA pyrimidine-5'-nucleotide nuclease gene ppnN UMP phosphohydrolase gene umpH and umpG Ribonucleotide hydrolase 1 gene rihA and glutamine synthase gene glnA Heterogeneous introduction of wild-type Bacillus subtilis B. subtilis 168 orotate nucleoside monophosphate decarboxylase gene pyrF and orotic acid ribosyltransferase gene pyrE To achieve safe, efficient, and low-cost production of uracil.
Owner:新疆瑞诺生物科技有限公司

Enzymatic synthesis of modified nucleoside triphosphate analogues

PCT designated stageWO2026112127A2Sugar derivativesEnzymesEnzymatic synthesisNucleoside monophosphate
The present disclosure generally relates to methods for the enzymatic synthesis of nucleotide triphosphates. In particular, the methods include a one-pot preparation of a modified nucleotide triphosphate starting from 3´-vinyl blocked nucleoside monophosphate.
Owner:ILLUMINA INC

Enzymatic synthesis of modified nucleoside triphosphate analogues

PendingUS20260146272A1TransferasesFermentationEnzymatic synthesisNucleoside monophosphate
The present disclosure generally relates to methods for the enzymatic synthesis of nucleotide triphosphates. In particular, the methods include a one-pot preparation of a modified nucleotide triphosphate starting from 3′-vinyl blocked nucleoside monophosphate.
Owner:ILLUMINA INC

A novel energy regeneration system, cell-free protein synthesis system comprising the same, kit and method

PendingCN122648518ANucleoside monophosphateCell free
The application provides a novel energy regeneration system, a cell-free synthesis system, a kit and a method. By using a nucleoside monophosphate or a salt thereof as a main component of the energy regeneration system, a conventional expensive NTP energy system component is replaced, and the problem of high cost of cell-free synthesis is effectively solved.
Owner:KANGMA (SHANGHAI) BIOTECH LTD

Multi-enzyme catalysis system and method for synthesizing functional glycan

PendingCN120989038ATransferasesFermentationAdenosine 5 monophosphateReceptor molecule
The invention belongs to the technical field of biosynthesis, and relates to a multi-enzyme catalysis system and method for synthesizing functional glycans. The system comprises a substrate module comprising nucleoside monophosphate, monosaccharide, polyphosphate and acceptor molecules; the nucleoside monophosphoric acid is one or more of uridine monophosphoric acid, adenosine monophosphoric acid, guanosine monophosphoric acid or cytidine monophosphoric acid; an enzyme module comprising a polyphosphate kinase, at least one remedial pathway synthetase, and at least one glycosyltransferase; the cofactor module comprises magnesium ions and optional inorganic pyrophosphatase; the system can realize in-situ regeneration of sugar nucleotide with nucleoside monophosphate as an initial cofactor and one-pot synthesis of target glycan. The invention systematically proposes that cheap NMP is used as a unique or main starting cofactor to replace expensive NTP or NDP for in-situ regeneration of various sugar nucleotides for the first time. Cofactor cost can be reduced by dozens of times, and a foundation is laid for large-scale production of glycans.
Owner:SHANDONG UNIV